rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-3-15
|
pubmed:abstractText |
To evaluate whether the single nucleotide polymorphism (SNP), Asp1104His (G3507C), in the XPG gene affects malignant phenotypes of nonmuscle-invasive urinary bladder neoplasms (NIBN), by investigating associations between the SNP and clinicopathological variables in patients with NIBN.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1464-4096
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
847-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16536785-Adult,
pubmed-meshheading:16536785-Aged,
pubmed-meshheading:16536785-Aged, 80 and over,
pubmed-meshheading:16536785-DNA-Binding Proteins,
pubmed-meshheading:16536785-Disease Progression,
pubmed-meshheading:16536785-Endonucleases,
pubmed-meshheading:16536785-Female,
pubmed-meshheading:16536785-Humans,
pubmed-meshheading:16536785-Male,
pubmed-meshheading:16536785-Middle Aged,
pubmed-meshheading:16536785-Neoplasm Staging,
pubmed-meshheading:16536785-Nuclear Proteins,
pubmed-meshheading:16536785-Polymerase Chain Reaction,
pubmed-meshheading:16536785-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:16536785-Polymorphism, Single Nucleotide,
pubmed-meshheading:16536785-Prospective Studies,
pubmed-meshheading:16536785-Survival Analysis,
pubmed-meshheading:16536785-Sweden,
pubmed-meshheading:16536785-Transcription Factors,
pubmed-meshheading:16536785-Urinary Bladder Neoplasms
|
pubmed:year |
2006
|
pubmed:articleTitle |
A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder.
|
pubmed:affiliation |
Department of Biosciences at Novum, Karolinska Institutet, Huddinge, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|